Wednesday, November 8, 2023
6:00PM – 7:00PM ET
Please note this TeleECHO program is 6:00PM Eastern, 5:00PM Central, 4:00PM Mountain and 3:00PM Pacific.
PRESENTING FACULTY
 |
Guillermo García-Manero, MD Professor, Chief, Section Myelodysplastic Syndrome Department of Leukemia Division of Cancer Medicine Houston, TX |
PROGRAM OVERVIEW
This virtually live activity has been designed for healthcare professionals to address the needs of patients with lower-risk myelodysplastic syndrome. In particular, the education will help learners diagnose myelodysplastic syndrome earlier and accurately stratify risk; recognize potential resistant to initial therapy in patients with lower-risk myelodysplastic syndrome; and apply best evidence-based practices and clinical data for initial and second-line therapeutic decisions for lower-risk myelodysplastic syndrome.
TARGET AUDIENCE
This program is designed to address the educational needs of the multidisciplinary hematology-oncology team, including hematologists, pathologists, nurses, and other multidisciplinary health care professionals working together to address the needs of patients with lower-risk myelodysplastic syndrome.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Interpret diagnostic criteria to enable early diagnosis of myelodysplastic syndrome with accurate risk stratification
- Evaluate the potential for resistance to initial therapy in patients with lower-risk myelodysplastic syndrome
- Use current evidence-based best practices and clinical data to inform choice of first- and second-line therapeutic options for patients with lower-risk myelodysplastic syndrome
ACCREDITATION STATEMENT
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Med Learning Group. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
NURSES (ANCC) CREDIT DESIGNATION
Amedco LLC designates this activity for a maximum of 1.0 ANCC contact hour.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CME activities that are science-based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at [email protected]
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]
